our best
ideas come
from the
ground up
Yogev Sarid, CEO
Subsidiaries
A groundbreaking company for mapping and isolating rare groups of phytochemicals in the cannabis plant. Eybna is conducting advanced research to understand the effects of certain plant components and to study their synergy (“Entourage Effect”), with the goal of developing the next generation of customized cannabis products. Moreover, Eybna specializes in the development and manufacture of natural formulations for enriching consumer products and among its customers are tier-1 international companies holding leading brands.
Specializes in R&D and manufacturing of innovative cannabis infused line of products for the medical & recreational cannabis markets, aimed to ensure a precise and controlled dosage of cannabinoids per use. TrichomShell’s revolutionary technology is already in licensed use by world-class cannabis manufacturers.
Targene, our collaboration with PlantArcBio, develops groundbreaking manufacturing capabilities of active plant ingredients (API). Targene produces cannabis extracts in controlled environment, using tissue culture technologies to commercially grow cannabis cells in sterile lab conditions, yielding accurate and consistent compound dosages for the Pharma industry. Targene also performs advanced strain optimization using gene editing and other advanced molecular techniques, producing personalized strains for end-users and for the pharmaceutical industry.
Owns the leading medical cannabis brand, “Canareet”. Holds a Portuguese subsidiary with an initial license to cultivate, manufacture, sell and distribute its medical cannabis products to the European market. The company operates academic courses in collaboration with the Technion – Israel’s institute of technology and operate an accelerator in the field of cannabis innovation. The company also establishing its presence in the medical cannabis market in South America in general and in Brazil in particular.
Seach Israel has been cultivating, perfecting, and supplying medical cannabis for over a decade. Seach Israel operates over 3.5 acres of fully automated, climate-controlled breeding and cultivation facilities, including an internal R&D lab and an extensive cannabis gene bank containing over 300 different cannabis strains. Seach Medical Group’s home brand, NITZAN, is cultivated in Seach Israel’s farm and widely used by major players in the Israeli Pharmaceuticals industry, providing Seach with a prominent position within the Israeli medical cannabis market.
Cann10 Portugal
Cann10 Brazil
international
Sarrio Hellas
DELIVERING A NEW STANDARD OF MEDICAL CANNABIS TO EUROPE – FROM EUROPE
Seach Medical Group’s subsidiary in Greece. The “Seed to sale” facility (15 acres) is under establishment process and located 80 kilometers north of Athens. The company shall cultivate, propagate, market and supply high quality medical cannabis products (EU-GMP) with the goal of becoming a leading supplier of high quality medical cannabis products to the developing European market. Sarrio Hellas’ products are powered and quality-assured by Seach’s vast professional expertise in medical cannabis.
A Netherlands-based company engages in the manufacturing, trade, marketing, clinical based researching, and distribution of CBD-based products, including its own branded line of products. The company currently works on product development and execution of clinical research in the field of CBD for animals.
collaborations
sub farm
My Green Fields
Strategic collaboration between Seach Medical Group and “My Green Fields” farm in the north of Israel. Considered to be one of the largest and most innovative farms in Israel, with a production capacity of approximately 19 tons per year.
sub farm
TELCANN
Strategic collaboration between Seach Medical Group and “Telcann” farm in the central of Israel. The farm was established and managed by the Telman family, who has vast knowledge and experience in the agricultural industry. The farm has a production capacity of several tons per year.
brands
cannareet
Cann10’s home brand, based on Seach Medical Group’s raw material and in compliance with GMP standards. The brand Includes both oils and inflorescence, currently sold in Israeli pharmacies. Cann10 uses Seach’s extensive experience to manufacture its products, to ensure the highest standard suitable for the pharma industry.
brands
AXIBAN
The first cannabis brand in Israel marketed by a pharmaceutical company, Rafa. Axiban oil, made from Seach’s raw material, is manufactured to the highest precision and in accordance with the highest production standards.
